m.soundcloud.com/prostate-o...
This podcast was done by Mark Scholz (my oncologist from Prostate Oncology Specialists). Very worthwhile information. He discusses off label uses. Some here oppose that but Scholz was using Taxotere long before it was approved by FDA. He was also combining zytega with lupron long before that early combination was shown to reduce deaths by over 40%. The main theme being drugs that are found useful to one stage may be also helpful at earlier stages. I’d welcome your comments.
Schwah